Correspondence 0001193125-24-072438 from JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT A (CIK 0000801019)
JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT A (CIK 0000801019)
Date: March 20, 2024 · CIK: 0000801019 · Accession: 0001193125-24-072438
AI Filing Summary & Sentiment
File numbers found in text: 333-254210, 811-4834
Show Raw Text
CORRESP 1 filename1.htm JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT A Table of Contents March 20, 2024 197 Clarendon Street Boston, Massachusetts 02116 (617) 572-0070 Email: mramirez@jhancock.com Michael A Ramirez AVP & Senior Counsel Mr. Sonny Oh U.S. Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Via EDGAR Correspondence Submission and Email Re: John Hancock Life Insurance Company (U.S.A.) Separate Account A Registration Statement Filed on December 1, 2023, regarding Rule 485(a) Post-Effective Amendment Filing to Form N-6 for Accumulation Variable Universal Life 2021 Policies (“AVUL 2021”) (333-254210) – Initial Summary Prospectus Dear Mr. Oh: On behalf of John Hancock Life Insurance Company (U.S.A.) (“John Hancock”) and its Separate Account A (811-4834), we are responding to the Commission staff comments that you provided on March 1, 2024, in connection with the Rule 485(a) amendment to add an Initial Summary Prospectus (“ISP”) to the Form N-6 Registration Statement. Sections of each prospectus cited in the below recitations of the Staff’s comments refer to the marked courtesy copies on which the Staff based its comments. Additionally, any applicable changes made in the attached courtesy copies of the prospectuses will be made in every other replicate prospectus which relies on the immediate Rule 485(a) filing. Comments to Statutory Prospectus Staff Comment 1: Please reconsider whether to include the Defined Benefit Chronic Illness Rider in the column for Investment Restrictions in the “Important Information” table. Response: We added the reference to the Defined Benefit Chronic Illness Rider accordingly. Staff Comment 2: Please remove the freestanding “e” on footnote 6. Response: Thank you for point this out and we have removed the error. Staff Comment 3: Please add the “Changes you may make” paragraph from the Initial Summary Prospectus (ISP) to the corresponding section of the Statutory Prospectus. Response: This paragraph has been added accordingly. Table of Contents Mr. Sonny Oh February 9, 2024 Page 2 Staff Comment 4: As in the ISP, remove “in years 1-10” in the Cash Value Enhancement Rider row of the FEE TABLE of the Statutory Prospectus. Response: We modified the disclosure accordingly. Comments to Form of Initial Summary Prospectus Staff Comment 5: On the last page of the ISP, please include the dates of the documents according to Rule 498A(b)(3)(i). Response: We included the date of the documents incorporated by reference. Staff Comment 6: Please confirm that the 1933 Act number, 1940 Act number, and Contract Identifier number are in a smaller font than that used in the rest of the prospectus. Response: While the font is smaller, we decreased the font further to make the distinction clearer. Comments to the Template Relief Letter Staff Comment 7: In the template request letter, add a footnote referencing the rule release for Rule 498A in the first representation. Response: We included a new footnote to the rule release. Staff Comment 8: In the SCHEDULE, include a third column indicating the date of last review of the registration statement for each replicate filing. Additionally, add a footnote that indicates that each of the replicate filings was updated per the adopting release. The purpose of these filings is to add an ISP for each. Response: We included this footnote with the requested information accordingly. We believe that the foregoing is responsive to the comments received to date on the Rule 485(a) filing of the AVUL 2021 statutory prospectus and ISP. The changes reflected will be incorporated into the Registration Statement via pre-effective amendment. If there are any questions or additional comments, please do not hesitate to reach me at 617-572-0070 or by email at mramirez@jhancock.com. Thank you, /s/ Michael A. Ramirez Michael A. Ramirez Table of Contents John Hancock Life Insurance Company (U.S.A.) Separate Account A John Hancock Life Insurance Company (U.S.A.) (“John Hancock USA”) Flexible Premium Variable Universal Life Insurance Policy with Indexed Accounts ACCUMULATION VARIABLE UNIVERSAL LIFE 2021 Prospectus dated [ ], 2024 You may choose to allocate your policy value to one or more of the options that the policies make available for that purpose. These options include our “variable investment accounts,” where the policy value will vary directly with the positive or negative investment experience of underlying investment “portfolios.” To provide you with that investment experience, amounts that you allocate to a variable investment account are held in a corresponding “subaccount” of John Hancock Life Insurance Company (U.S.A.) Separate Account A (“Separate Account”), and the subaccount invests those amounts exclusively in one of the portfolios. You may also allocate policy value to a fixed indexed account (“indexed account”) or to a “fixed account” that the policy makes available. This prospectus provides detailed information about all such options to which you can allocate your policy value. Please note that the Securities and Exchange Commission (“SEC”) has not approved or disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. Additional information about certain investment products, including variable life insurance, has been prepared by the SEC’s staff and is available at Investor.gov. If you are a new investor, you may cancel your policy within 10 days of receiving it without paying fees or penalties. In some states (or if your policy replaces another policy), this cancellation period may be longer. Upon cancellation, you will receive either a full refund of the amount you paid with your application or your total policy value. You should review this prospectus, or consult with your investment professional, for additional information about the specific cancellation terms that apply. Table of Contents TABLE OF CONTENTS IMPORANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY 5 OVERVIEW OF THE POLICY 8 Purpose 8 Premiums 8 Policy Features 8 Death benefit 8 Surrender of the policy 8 Withdrawals 8 Policy loans 9 Policy credit 9 Supplementary benefit riders 9 FEE TABLE 10 GENERAL DESCRIPTION OF THE POLICY 14 Policy Rights 14 Owner and beneficiary 14 Allocation of Premiums 14 Transfers of Policy Value 15 Limitations on transfers to or from a variable investment account 15 Frequent transfers among variable investment accounts 15 Limitations on transfers out of the fixed account 16 Limitations on transfers to and from an indexed account 16 Potential additional limitations 16 Dollar cost averaging and asset allocation balancer programs 16 General Account 17 The fixed account 17 The indexed accounts 17 PREMIUMS 24 Purchase Procedures 24 Premium Amount 24 Premium Due Dates 24 No-lapse Guarantee 25 STANDARD DEATH BENEFITS 26 Standard Death Benefits 26 Effectiveness and Policy Date 26 Temporary insurance coverage 26 Option 1 and Option 2 26 Base Face Amount and Supplemental Face Amount 27 Minimum death benefit 27 Calculation and payment of the death benefit 28 Additional Information About Standard Death Benefits 28 Requesting an increase or decrease in coverage 28 Change of death benefit option 28 Tax consequences of coverage changes 28 Limitations on payment of death benefit 30 SURRENDERS AND WITHDRAWALS 31 Surrender and Withdrawal 31 Additional Information Regarding Surrender and Withdrawal 31 Cancellation Rights 31 2 Table of Contents LOANS 32 Availability of Loans, Limitations and Interest 32 Effect of Loans on Cash Value and Death Benefit 32 Other Effects of Loans 33 Loan Repayments 33 OTHER BENEFITS AVAILABLE UNDER THE POLICY 34 More About Certain Optional Benefits 37 Healthy Engagement Rider 37 Critical Illness Benefit Rider 38 Disability Payment of Specified Premium Rider 39 Long-Term Care Rider 40 Long-Term Care Rider 2018 41 Return of Premium Death Benefit Rider 41 Cash Value Enhancement Rider 42 Overloan Protection Rider 43 Accelerated Benefit Rider 43 Healthy Engagement Core Rider 43 Accelerated Death Benefit for Chronic Illness Rider 44 Defined Benefit Chronic Illness Rider 44 TAXES 46 Tax Consequences of Owning a Policy 46 Effect on the Company’s Taxes 48 PRINCIPAL RISKS OF INVESTING IN THE POLICY 49 Lapse Risk 49 Investment Risk/Risk of Loss 49 Risks Associated with Indexed Accounts 49 Transfer Risk 49 Early Surrender or Withdrawal Risk/Not a Short-Term Investment 50 Tax Risks 50 ADDITIONAL INFORMATION REGARDING THE POLICY 50 Charges 50 Deductions from premium payments 50 Deductions from policy value 51 Charges at the portfolio level 52 Additional Information About How Certain Policy Charges Work 52 Other Charges We Could Impose in the Future 52 Commissions Paid to Dealers 52 Lapse and Reinstatement 53 Lapse 53 Reinstatement 53 Variations 53 Policy or Separate Account Changes 54 When We Pay Policy Proceeds 55 Coverage at and After Age 121 55 GENERAL DESCRIPTION OF REGISTRANT, DEPOSITOR AND PORTFOLIOS 57 Depositor 57 Registrant 57 Portfolios 57 Voting Portfolio Shares 57 LEGAL PROCEEDINGS 58 3 Table of Contents FINANCIAL STATEMENTS 58 APPENDIX: PORTFOLIOS AVAILABLE UNDER THE POLICY Appendix-1 4 Table of Contents IMPORANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY FEES AND EXPENSES Charges for Early Withdrawals There are surrender charges assessed upon surrender, withdrawal, or policy lapse in the first fifteen policy years from the Policy Date The maximum surrender charge is 5.92% of Base Face Amount. For example, if the Base Face Amount is $100,000, the highest possible surrender charge would be $5,924. FEE TABLE Deductions from policy value Transaction Charges In addition to surrender charges (if applicable), you may also be charged for the following transactions: A premium charge will be deducted from each premium paid. A transfer fee may be deducted upon transfers into or out of a variable investment account after you have made more than 12 such transfers in a year. FEE TABLE Deductions from premium payments Deductions from policy value Ongoing Fees and Expenses (annual charges) In addition to surrender charges and transaction charges, you will also be subject to certain ongoing fees and expenses, including a cost of insurance charge, administrative charge, Base Face Amount charge, Supplemental Face Amount charge, asset-based risk charge, indexed performance charge, policy loan costs, and supplementary benefit rider charges. Some of these fees and expenses are based wholly or in part on the characteristics of the insured person (e.g., age, sex, and underwriting classification). You should view the “policy specifications” page of your policy for rates applicable to your policy. You will also bear expenses associated with the portfolios under the policy, as shown in the following table: FEE TABLE Deductions from policy value Charges at the portfolio level Annual Fee Minimum Maximum APPENDIX Variable investment accounts (portfolio fees and expenses) [ ]% [ ]% RISKS Risk of Loss You can lose money by investing in this policy. PRINCIPAL RISKS OF INVESTING IN A POLICY Not a Short-Term Investment This policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The policy is unsuitable as a short-term savings vehicle because of substantial policy-level charges, including the premium charge and the surrender charge, as well as potential adverse tax consequences from such short-term use. Early Surrender or Withdrawal Risk/Not a Short-Term Investment Risks Associated with Investment Options An investment in this policy is subject to the risk of poor performance and can vary depending on the performance of the account allocation options available under the policy (e.g., portfolios). Each such option (including the fixed account and indexed accounts) will have its own unique risks, and you should review these options before making an allocation decision. Investment Risk/Risk of Loss Risks Associated with Indexed Accounts 5 Table of Contents RISKS Insurance Company Risks Your investment in the policy is subject to risks related to John Hancock USA, including that the obligations, the fixed account and indexed accounts, guarantees, or benefits are subject to the claims- paying ability of John Hancock USA. Information about John Hancock USA, including its financial strength ratings, is available upon request from your John Hancock USA representative. Our current financial strength ratings can also be obtained by contacting the Service Office at 1-800-732-5543. Depositor Registrant Policy Lapse Unless the No-Lapse Guarantee is in effect, this policy will go into default if at the beginning of any policy month the policy’s net cash surrender value would be zero or below after deducting the monthly deductions then due. The “net cash surrender value” is your policy value, less any policy debt, and less any applicable surrender charges. This can happen as a result of insufficient premium payments, poor performance of the variable or general account options you have chosen, withdrawals, or unpaid loans or loan interest. If a default is not cured within a 61-day grace period, your policy will lapse without value, and no death benefit or other benefits will be payable. You can apply to reinstate a policy that has gone into default, subject to conditions including payment of a specified amount of additional premiums. Lapse and Reinstatement RESTRICTIONS Investments There are restrictions that may limit the variable investment account options and general account options, the fixed account and indexed accounts that you may choose, as well as limitations on the transfer of policy value among those options. These restrictions may include a monthly limit on the number of transfers you may make. We may also impose additional restrictions to discourage market timing and disruptive trading activity. In particular, your allocation options will be affected if you elect to take a loan or receive benefits under certain supplementary benefit riders. Among other things, the policy also allows us to eliminate the shares of a portfolio or substitute shares of another new or existing portfolio, subject to applicable legal requirements. Limitations on transfers to or from a variable investment account Limitations on transfers out of the fixed account Effect of Loans on Cash Value and Death Benefit Long-Term Care Rider, Long-Term Care Rider 2018 and Overloan Protection Rider Defined Benefit Chronic Illness Rider Portfolios and The Indexed Accounts Optional Benefits There are restrictions and limitations relating to optional benefits, as well as conditions under which an optional benefit may be modified or terminated by us. For example, certain supplementary benefit riders may be subject to underwriting, and your election of an option may result in restrictions upon some of the policy benefits, including availability of investment options. Return of Premium Death Benefit Rider Overloan Protection Rider Defined Benefit Chronic Illness Rider More About Certain Optional Benefits 6 Table of Contents TAXES Tax Implications You should consult with a tax professional to determine the tax implications of an investment in and payments received under the policy. There is no additional tax benefit to you if the policy is purchased through a tax-qualified plan or an individual retirement account (IRA). If we pay out any amount of your poli